Gao Bipolar Spectrum Lithium/Quetiapine Study
This study evaluates the safety and effectiveness of lithium for people with bipolarity.
Understand this study
What is this study about?
This study evaluates the safety and effectiveness of lithium for people with bipolarity.
Who could participate?
Listed age limits: from 18 years.
- Listed locations
- ClevelandSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 42
- Sponsor
- University Hospitals Cleveland Medical Center
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- Over 18 Years
- Official registry ID
- NCT01526148
- Official title
Show the full official title
Comparative Safety, Tolerability, and Effectiveness of Lithium Versus Quetiapine in Patients Across the Spectrum of Bipolar Disorder
Recruitment & locations
Cleveland
Interested in joining this study?
Questions about this study
What is this study about?
This study evaluates the safety and effectiveness of lithium for people with bipolarity.
Who is behind this study?
The study sponsor is University Hospitals Cleveland Medical Center, a university.
Does this study involve medication?
Yes. The study involves medication, including lithium and Quetiapine.
Who can participate?
Listed age limits: from 18 years.
Is this study still recruiting?
The registry lists this study as terminated.
